Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Zanatta

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Rheumatology (Oxford, England)|June 3, 2025
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohortStefano Di Donato, John D Pauling, Sheila Ramjug, et al.
RMD Open|June 9, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian studyGiulia Buonsante, Giacomo De Luca, Elena Marazzi, et al.
Rheumatology (Oxford, England)|February 13, 2021
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohortMaria-Grazia Lazzaroni, Emiliano Marasco, Corrado Campochiaro, et al.
Journal of Scleroderma and Related Disorders|April 7, 2022
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definitionCosimo Bruni, Maya H Buch, Daniel E Furst, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrumClodoveo Ferri, Dilia Giuggioli, Serena Guiducci, et al.
Clinical Rheumatology|May 15, 2025
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for RheumatologyMartina Orlandi, Giacomo De Luca, Clodoveo Ferri, et al.
Therapeutic Advances in Musculoskeletal Disease|July 16, 2025
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR)Martina Orlandi, Dilia Giuggioli, Clodoveo Ferri, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Rheumatology (Oxford, England)|June 3, 2025
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohortStefano Di Donato, John D Pauling, Sheila Ramjug, et al.
RMD Open|June 9, 2026
Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian studyGiulia Buonsante, Giacomo De Luca, Elena Marazzi, et al.
Rheumatology (Oxford, England)|February 13, 2021
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohortMaria-Grazia Lazzaroni, Emiliano Marasco, Corrado Campochiaro, et al.
Journal of Scleroderma and Related Disorders|April 7, 2022
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definitionCosimo Bruni, Maya H Buch, Daniel E Furst, et al.
RMD Open|November 8, 2018
Systemic sclerosis: state of the art on clinical practice guidelinesVanessa Smith, Carlo Alberto Scirè, Rosaria Talarico, et al.
RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.
Journal of Personalized Medicine|April 28, 2023
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS)Margherita Zen, Mariele Gatto, Roberto Depascale, et al.
Clinical and Experimental Rheumatology|April 18, 2020
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrumClodoveo Ferri, Dilia Giuggioli, Serena Guiducci, et al.
Clinical Rheumatology|May 15, 2025
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for RheumatologyMartina Orlandi, Giacomo De Luca, Clodoveo Ferri, et al.
Therapeutic Advances in Musculoskeletal Disease|July 16, 2025
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR)Martina Orlandi, Dilia Giuggioli, Clodoveo Ferri, et al.
Pageof 10